Developments in CAR T-cell Therapy

Join EHA President Prof Konstanze Döhner from University Hospital Ulm in Germany as she discusses her deep interest in hematology, both in research and in the clinics. Listen as Prof. Döhner shares why she decided to focus on Acute Myeloid Leukemia (AML) and myeloproliferative ne ...  Show more

In this episode, Dr Michael Milsom discusses how thehematopoietic system aging is a complex process with multiple causes. Dr Milsom proposes a more holistic view of the driving mechanisms of hematopoietic andimmune aging that does not focus solely on HSCs. He describes how inflam ...  Show more

Join Dr. Jerry Yoo as he sits down with Dr. Tom Buchheit, Director of the Regenerative Pain Therapies Program at Duke University. In this episode, Dr. Buchheit shares insights into how regenerative medicine and regenerative physical therapy can potentially spare individuals f ...

When I first had Mark Dixon on the podcast, way back in Session 14, we poked some fun at the notion that principles of Acceptance and Commitment Therapy, on the surface, didn't meet many of the 7 dimensions of Applied Behavior Analysis. Well, in Session 50, I'm joined by Dr. Jona ...  Show more

If you are wondering about the future role of AI in clinical care, this is an episode you must listen to. In this episode co-hosted with MohammadAli Jardaly, we discuss with the integration of AI into clinical care with Dr. Hussain Ismaeel (who is the co-founder of Healtech). ...

In this week’s episode, we pause from our discussion about DLBCL to talk about the fundamentals of CAR-T, BiTE and autologous transplants, which will lay the foundation for subsequent discussions about DLBCL. These therapies are the talk ...